IL249127D0
Anti-pd-l1 antibodies and their use to enhance t-cell function
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
157 members in 41 offices
Priority claims6
| Document | Office | Kind | Date |
|---|---|---|---|
| 12109208 | United States of America | P | |
| 2009067104 | United States of America | W | |
| 61121092 | – | – | – |
| PCTUS2009067104 | – | – | – |
| US20080121092P | – | – | – |
| WO2009US67104 | – | – | – |
Members157
| Document | Office | Kind | |
|---|---|---|---|
| AU2009333580A1 | Australia | A1 | |
| CA2740806A1 | Canada | A1 | |
| CA3120172A1 | Canada | A1 | |
| WO2010077634A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2010203056A1 | United States of America | A1 | |
| TW201032822A | Taiwan Province of China | A | |
| AR074563A1 | Argentina | A1 | |
| CR20110316A | Costa Rica | A | |
| SG172059A1 | Singapore | A1 | |
| ECSP11011115A | Ecuador | A | |
| IL213353A0 | Israel | A0 | |
| IL213353D0 | Israel | D0 | |
| MX2011005853A | Mexico | A | |
| KR20110092300A | Republic of Korea | A | |
| EP2376535A1 | European Patent Office (EPO) | A1 | |
| CN102245640A | China | A | |
| MA32948B1 | Morocco | B1 | |
| CL2011001382A1 | Chile | A1 | |
| CO6390023A2 | Colombia | A2 | |
| PE20120341A1 | Peru | A1 | |
| JP2012511329A | Japan | A | |
| US8217149B2 | United States of America | B2 | |
| HK1163130A | Hong Kong, China | A | |
| HK1163130A1 | Hong Kong, China | A1 | |
| RU2011128399A | Russian Federation | A | |
| US2013045200A1 | United States of America | A1 | |
| US2013045201A1 | United States of America | A1 | |
| US2013045202A1 | United States of America | A1 | |
| ZA201102417B | South Africa | B | |
| NZ592119A | New Zealand | A | |
| TWI419705B | Taiwan Province of China | B | |
| SG196798A1 | Singapore | A1 | |
| US2014065135A1 | United States of America | A1 | |
| TW201417828A | Taiwan Province of China | A | |
| PE20141722A1 | Peru | A1 | |
| CN102245640B | China | B | |
| JP5681638B2 | Japan | B2 | |
| CN104479018A | China | A | |
| JP2015091260A | Japan | A | |
| UA109108C2 | Ukraine | C2 | |
| US2015322153A1 | United States of America | A1 | |
| BRPI0917592A2 | Brazil | A2 | |
| HK1207387A | Hong Kong, China | A | |
| HK1207387A1 | Hong Kong, China | A1 | |
| AU2016203867A1 | Australia | A1 | |
| AU2009333580B2 | Australia | B2 | |
| US2016222117A1 | United States of America | A1 | |
| MX342591B | Mexico | B | |
| CR20160570A | Costa Rica | A | |
| IL249127A0 | Israel | A0 | |
| IL249127D0This record | Israel | D0 | |
| TW201712034A | Taiwan Province of China | A | |
| EP2376535B1 | European Patent Office (EPO) | B1 | |
| US2017107287A1 | United States of America | A1 | |
| IL213353A | Israel | A | |
| DK2376535T3 | Denmark | T3 | |
| PT2376535T | Portugal | T | |
| LT2376535T | Lithuania | T | |
| SMT201700311T1 | San Marino | T1 | |
| SI2376535T1 | Slovenia | T1 | |
| ES2628095T3 | Spain | T3 | |
| JP6178349B2 | Japan | B2 | |
| JP2017136085A | Japan | A | |
| EP2376535B9 | European Patent Office (EPO) | B9 | |
| HRP20170908T1 | Croatia | T1 | |
| KR101782570B1 | Republic of Korea | B1 | |
| PL2376535T3 | Poland | T3 | |
| KR20170113681A | Republic of Korea | A | |
| NZ717213A | New Zealand | A | |
| RU2636023C2 | Russian Federation | C2 | |
| TWI605828B | Taiwan Province of China | B | |
| LUC00051I1 | Luxembourg | I1 | |
| EP3255060A1 | European Patent Office (EPO) | A1 | |
| HUS1700049I1 | Hungary | I1 | |
| SG10201708690SA | Singapore | A | |
| CY1118943T1 | Cyprus | T1 | |
| LTPA2017041I1 | Lithuania | I1 | |
| FR17C1050I1 | France | I1 | |
| NL300914I2 | Netherlands (Kingdom of the) | I2 | |
| NO2018006I1 | Norway | I1 | |
| AU2016203867B2 | Australia | B2 | |
| LUC00051I2 | Luxembourg | I2 | |
| US9920123B2 | United States of America | B2 | |
| CY2017043I1 | Cyprus | I1 | |
| CY2017043I2 | Cyprus | I2 | |
| MX356367B | Mexico | B | |
| AU2018203226A1 | Australia | A1 | |
| KR20180089573A | Republic of Korea | A | |
| CN104479018B | China | B | |
| HK1247621A | Hong Kong, China | A | |
| HK1247621A1 | Hong Kong, China | A1 | |
| CN108997498A | China | A | |
| FR17C1050I2 | France | I2 | |
| US2019016807A1 | United States of America | A1 | |
| IL263931D0 | Israel | D0 | |
| RU2017132160A | Russian Federation | A | |
| EP3447073A1 | European Patent Office (EPO) | A1 | |
| IL249127A | Israel | A | |
| IL249127B | Israel | B | |
| JP6509935B2 | Japan | B2 |
Showing 100 of 157
3 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF |
Numbers
- Publication, DOCDB
- 249127
- Publication, EPODOC
- IL249127D
- Application
- 249127
- Application, DOCDB
- 24912716
- Application, EPODOC
- IL20160249127
Titles2
- English
- Anti-pd-l1 antibodies and their use to enhance t-cell function
- Hebrew
- נוגדנים אנטי pd–l1 ושימוש בהם להגברת תפקוד תא t
Classification
- CPC, 36
- C07K16/2827
- A61K39/3955
- A61K2039/505
- A61K2039/507
- C07K16/1063
- C07K16/22
- C07K2317/56
- C07K2317/565
- C07K2317/567
- C07K2317/71
- C07K2317/92
- C07K2317/73
- C07K2317/74
- C07K2317/76
- A61P31/00
- A61P31/04
- A61P31/10
- A61P31/12
- A61P33/00
- A61P33/02
- A61P35/00
- A61P37/00
- A61P37/02
- A61P37/04
- A61P43/00
- Y02A50/30
- C07K16/28
- A61K39/39558
- C07K16/30
- A61K31/7068
- A61K45/06
- A61K39/00
- C07K16/3046
- C07K2317/14
- C07K2317/24
- C07K2317/52
- IPC, 1
- C07K